Amit Gupta - 23 Jan 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Operating Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
23 Jan 2023
Net transactions value
$0
Form type
4
Filing time
23 Jan 2023, 15:40:23 UTC
Next filing
24 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Unit Award $0 +350,000 $0.000000 350,000 23 Jan 2023 Common Stock 350,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2 50% of the RSUs shall vest on January 23, 2024 (the "Anniversary Date"), with the remaining 50% vesting in equal amounts quarterly over one year after the Anniversary Date, provided that the Reporting Person remains employed by the Issuer on such vesting date.